CN Patent

CN105348265A — 一种具有ALK和c-Met抑制活性的2,4-二取代杂环三氮唑类化合物的制备和应用

Assigned to Individual · Expires 2016-02-24 · 10y expired

What this patent protects

本发明涉及式(I)2，4-二取代杂环三氮唑类化合物的制备及其应用，其中R1和R2的定义见说明书。本发明提供的式(I)化合物是ALK和c-Met激酶抑制剂，通过阻断信号通路，终止下游信号级联通路，发挥抑制癌细胞增殖的作用。式(I)化合物可作为潜在的抗癌治疗药物。

USPTO Abstract

本发明涉及式(I)2，4-二取代杂环三氮唑类化合物的制备及其应用，其中R1和R2的定义见说明书。本发明提供的式(I)化合物是ALK和c-Met激酶抑制剂，通过阻断信号通路，终止下游信号级联通路，发挥抑制癌细胞增殖的作用。式(I)化合物可作为潜在的抗癌治疗药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN105348265A
Jurisdiction
CN
Classification
—
Expires
2016-02-24
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.